Skip to main content

Table 3 LRG1 peptides identified by mass spectrometry

From: Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients

Depletion

experiment

# of

unique

peptides

Peptide sequence

Peptide

sequence

confidence

Sequence coverage

m/z

MARS SC†

3

TLDLGENQLETLPPDLLR

99

192-209

2037.29

  

DLLLPQPDLR

31

230-239

1179.37

  

VTLSPK

N/A

36-41

643.76

IgY-12 SC†

6

LQELHLSSNGLESLSPEFLRPVPQ

99

94-117

2691.03

  

ALGHLDLSGNR

99

165-175

1152.26

  

TLDLGENQLETLPPDLLR

99

192-209

2037.29

  

DLLLPQPDLR

98

230-239

1179.37

  

LQVLGK

27

224-229

656.81

  

YLFLNGNK

13

240-247

968.1

IgY-12 LC†

10

ALGHLDLSGNR

99

165-175

1152.26

  

TLDLGENQLETLPPDLLR

99

192-209

2037.29

  

VAAGAFQGLR

99

251-260

989.13

  

GQTLLAVAK

99

337-345

900.07

  

DLLLPQPDLR

98

230-239

1179.37

  

LHLEGNKLQVLGK

97

217-229

1448.71

  

YLFLNGNK

89

240-247

968.1

  

GPLQLER

81

210 216

811.92

  

LQVLGK

24

224-229

656.81

  

VLDLTR

8

120-125

715.84

IgY-12 LC‡

6

VAAGAFQGLR

95

251-260

989.13

  

YLFLNGNK

95

240-247

968.1

  

ALGHLDLSGNR

95

165-175

1152.26

  

GQTLLAVAK

95

337-345

900.07

  

DLLLPQPDLR

95

230-239

1179.37

  1. † iTRAQ® labeling; ‡Differential in-gel electrophoresis labeling.